Biocon registers consolidated revenue of Rs 4519 crore in Q3 Ruchika Sharma9 Feb 2024 4:03 PM ISTBengaluru: Bengaluru, Biocon Ltd, the Bengaluru-based pharmaceutical giant has announced its consolidated financial results for the fiscal third...
USFDA gives tentative nod to Biocon for cancer drug Dasatinib Ruchika Sharma7 Feb 2024 12:43 PM ISTBangalore: Biocon Limited has received tentative approval of its Abbreviated New Drug Application (ANDA) for Dasatinib tablets from the United...
Powered by innovative drugs, pharma industry can be worth USD 200 billion by 2030: Biocon Chief Ruchika Sharma25 Jan 2024 12:17 PM ISTMazumdar-Shaw also sought that the government ought to decouple private sector investment and ensure that academic research institutes are funded out...
CVS Health to remove AbbVie rheumatoid arthritis drug Humira from some drug reimbursement lists in April Ruchika Sharma4 Jan 2024 12:30 PM ISTA CVS spokesperson said the company expects most of its customers to transition their coverage to biosimilars of Humira, known chemically as...
Biocon Biologics, Sandoz ink pact for distribution of immune disorder injection Adalimumab in Japan Ruchika Sharma23 Dec 2023 12:30 PM ISTAdalimumab BS for subcutaneous injection [FKB] is a biosimilar of Humira (generic name: adalimumab (genetical recombination)) and is indicated for...
Biocon arm completes integration of Viatris biosimilars business in 120 countries Ruchika Sharma19 Dec 2023 11:43 AM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced the successful completion of the transition of the acquired...
Biocon associate co Bicara Therapeutics raises over Rs 1375 crore in series C financing Ruchika Sharma14 Dec 2023 1:30 PM ISTBoston: Bicara Therapeutics, an associate company of Biocon Limited, has announced the completion of an oversubscribed $165 million Series C...
Biocon arm concludes integration of Viatris biosimilar business in 31 European countries Ruchika Sharma30 Nov 2023 5:33 PM ISTBengaluru: Biocon Biologics Ltd, a subsidiary of Biocon Ltd has announced that the integration of the Viatris' biosimilars business in 31...
Biocon arm gets UK MHRA marketing authorisation for ophthalmic drug Yesafili Ruchika Sharma14 Nov 2023 11:29 AM ISTIt is highly similar to the reference product Eylea (aflibercept).
Biocon misses Q2 profit view on higher expenses Ruchika Sharma11 Nov 2023 12:15 PM ISTHyderabad: Indian biopharmaceutical company Biocon reported a smaller-than-expected quarterly profit hurt by higher expenses.The company's...
Biocon Biologics to divest dermatology, nephrology branded formulations business units in India to Eris Lifesciences for Rs 366 crore Ruchika Sharma9 Nov 2023 11:45 AM ISTThe divestiture is expected to close by the end of Nov 2023, subject to customary closing conditions.
Ex Cipla Global CFO Kedar Upadhye appointed as new CFO of Biocon Biologics Ruchika Sharma20 Oct 2023 2:30 PM ISTBengaluru: Biocon Biologics Ltd, a subsidiary of Biocon Ltd has announced that the Board of Directors of Biocon Biologics have appointed Kedar Upadhye...
